Ginsenoside Rb1 relieves glucose fluctuationinduced oxidative stress and apoptosis in Schwann cells

Neural Regeneration Research

Volumn 7, Issue 30, 2012, Pages 2340-2346

  Xue, Bing ^a   Sun, Lianqing ^a   Li, Xiaojin ^a   Wang, Xuan ^a   Zhang, Ying ^b   Mu, Yiming ^a   Liang, Linlang ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Apoptosis; Chinese herb; Diabetic peripheral neuropathy; Ginsenoside Rb1; Glucose fluctuation; Neural regeneration; Neuroprotection; Oxidative stress; Schwann cells

Indexed keywords

EID: 84925967705     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2012.30.003     Document Type: Article

References (36)

1. [1] Edwards JL, Vincent AM, Cheng HT, et al. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 2008;120(1):1-34.
2. [2] Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9(4): 301-314.
3. [3] Vincent AM, McLean LL, Backus C, et al. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J. 2005;196(6):638-640.
4. [4] Habib AA, Brannagan TH 3rd. Therapeutic strategies for diabetic neuropathy. Curr Neurol Neurosci Rep. 2010; 10(2):92-100.
5. [5] Vincent AM, Callaghan BC, Smith AL, et al. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol. 2011;7(10):573-583.
6. [6] Xiong Y, Shen L, Liu KJ, et al. Antiobesity and antihyperglycemic effects of ginsenoside Rb1 in rats. Diabetes. 2010;59(10):2505-2512.
7. [7] Wu Y, Xia ZY, Dou J, et al. Protective effect of ginsenoside Rb1 against myocardial ischemia/reperfusion injury in treptozotocin-induced diabetic rats. Mol Biol Rep. 2011; 38(7):4327-4335.
8. [8] Muona P, Jaakkola S, Salonen V, et al. Expression of glucose transporter 1 in adult and developing human peripheral nerve. Diabetologia. 1993;36(2):133-140.
9. [9] Magnani P, Cherian PV, Gould GW, et al. Glucose transporters in rat peripheral nerve: paranodal expression of GLUT1 and GLUT3. Metabolism. 1996;45(12): 1466-1473.
10. [10] Gumy LF, Bampton ET, Tolkovsky AM. Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol Cell Neurosci. 2008;37(2): 298-311.
11. [11] Shi XL, Ren YZ, Wu J. Intermittent high glucose enhances apoptosis in INS-1 cells. Exp Diabetes Res. 2011;2011: 754673.
12. [12] Piconi L, Quagliaro L, Assaloni R, et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev. 2006;22(3): 198-203.
13. [13] Horváth EM, Benko R, Kiss L, et al. Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus. Diabetologia. 2009;52(5):952-961.
14. [14] Qu L, Liang XC, Zhang H, et al. Effect of Jinmaitong serum on the proliferation of rat Schwann cells cultured in high glucose medium. Chin J Integr Med. 2008;14(4): 293-297.
15. [15] Wu LL, Chiou CC, Chang PY, et al. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta. 2004;339(1-2):1-9.
16. [16] Sumner CJ, Sheth S, Griffin JW, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60(1):108-111
17. [17] Delaney CL, Russell JW, Cheng HL, et al. Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. J Neuropathol Exp Neurol. 2001;60(2):147-160.
18. [18] Suzuki T, Sekido H, Kato N, et al. Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway. J Neurochem. 2004;91(6):1430-1438.
19. [19] Sango K, Suzuki T, Yanagisawa H, et al. High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32. J Neurochem. 2006;98(2): 446-458.
20. [20] Min S, Jian-Bo L, Hong-Man Z, et al. Neuritin is expressed in Schwann cells and down-regulated in apoptotic Schwann cells under hyperglycemia. Nutr Neurosci. in press.
21. [21] Lee HC, Wei YH. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood). 2007;232(5):592-606.
22. [22] Leinninger GM, Edwards JL, Lipshaw MJ, et al. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol. 2006;2(11):620-628.
23. [23] Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells. Diabetes. 2003; 52(11):2795-2804.
24. [24] Zhu J, Jiang Y, Wu L, et al. Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia. Neuroscience. 2012;202:342-351.
25. [25] Lo YT, Tsai YH, Wu SJ, et al. Ginsenoside Rb1 inhibits cell activation and liver fibrosis in rat hepatic stellate cells. J Med Food. 2011;14(10):1135-1143.
26. [26] Wang Z, Li M, Wu WK, et al. Ginsenoside Rb1 preconditioning protects against myocardial infarction after regional ischemia and reperfusion by activation of phosphatidylinositol-3-kinase signal transduction. Cardiovasc Drugs Ther. 2008;22(6):443-452.
27. [27] Kamboj SS, Vasishta RK, Sandhir R. N-acetylcysteine inhibits hyperglycemia- induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem. 2010;112(1):77-91.
28. [28] Malhotra A, Vashistha H, Yadav VS, et al. Inhibition of p66ShcA redox activity in cardiac muscle cells attenuates hyperglycemia-induced oxidative stress and apoptosis. Am J Physiol Heart Circ Physiol. 2009;296(2):380-388.
29. [29] Allen DA, Harwood S, Varagunam M, et al. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J. 2003;17(8):908-910.
30. [30] Le Bras M, Clément MV, Pervaiz S, et al. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol. 2005;20(1):205-219.
31. [31] Mehmeti I, Lenzen S, Lortz S. Modulation of Bcl-2-related protein expression in pancreatic beta cells by pro-inflammatory cytokines and its dependence on the antioxidative defense status. Mol Cell Endocrinol. 2011; 332(1):88-96.
32. [32] Azad N, Iyer A, Vallyathan V, et al. Role of oxidative/nitrosative stress-mediated Bcl-2 regulation in apoptosis and malignant transformation. Ann N Y Acad Sci. 2010;1203:1-6.
33. [33] Folli F, Corradi D, Fanti P, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. 2011;7(5):313-324.
34. [34] Karasu C. Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment. Open Cardiovasc Med J. 2010;4: 240-256.
35. [35] Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615-1625.
36. The Ministry of Science and Technology of the People’s Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.